BCV
UTHR icon

Banque Cantonale Vaudoise’s United Therapeutics UTHR Stock Holding History

Banque Cantonale Vaudoise’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58K Buy
2,908
+496
+21% +$279K ﹤0.01% 390
2026
Q1 		$1.43M Buy
2,412
+484
+25% +$241K 0.05% 320
2025
Q4 		$939K Buy
+1,928
New +$898K 0.03% 370
2025
Q2 		– Sell
-1,042
Closed -$321K – 866
2025
Q1 		$321K Buy
+1,042
New +$357K 0.01% 505
2023
Q4 		– Sell
-1,036
Closed -$234K – 1194
2023
Q3 		$234K Sell
1,036
-631
-38% -$145K 0.01% 638
2023
Q2 		$368K Buy
1,667
+1,370
+461% +$303K 0.02% 562
2023
Q1 		$67K Hold
297
– – ﹤0.01% 911
2022
Q4 		$83K Sell
297
-37
-11% -$9.34K ﹤0.01% 885
2022
Q3 		$70K Buy
334
+44
+15% +$9.84K ﹤0.01% 934
2022
Q2 		$68K Sell
290
-138
-32% -$28.1K ﹤0.01% 946
2022
Q1 		$77K Hold
428
– – ﹤0.01% 969
2021
Q4 		$92K Hold
428
– – ﹤0.01% 971
2021
Q3 		$79K Sell
428
-196
-31% -$38.6K ﹤0.01% 985
2021
Q2 		$112K Hold
624
– – 0.01% 945
2021
Q1 		$104K Buy
624
+83
+15% +$13.8K 0.01% 905
2020
Q4 		$82K Sell
541
-3
-0.6% -$394 ﹤0.01% 875
2020
Q3 		$55K Sell
544
-24
-4% -$2.63K ﹤0.01% 898
2020
Q2 		$69K Buy
+568
New +$63.9K 0.01% 813

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Banque Cantonale Vaudoise's UTHR Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its United Therapeutics (UTHR) stake by 21% in Q2 2026, buying an estimated $279K and bringing the position to 2,908 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Banque Cantonale Vaudoise first reported a position in UTHR in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.43M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Banque Cantonale Vaudoise held 2,908 shares of United Therapeutics worth $1.58K as of Q2 2026.
  • Banque Cantonale Vaudoise bought 496 United Therapeutics shares in Q2 2026, an estimated $279K.
  • United Therapeutics made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #390 holding.
  • Banque Cantonale Vaudoise first reported a position in United Therapeutics in Q2 2020 and has held it in 18 quarters since.
  • Banque Cantonale Vaudoise's United Therapeutics position peaked at $1.43M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.